> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# AvKare Recalls Sildenafil, Trazodone Due to Mix-up
- URL: https://www.fdaweb.com/avkare-recalls-sildenafil-trazodone-due-to-mix-up/
- Published: 2020-12-10T12:00:00.000Z
- Updated: 2026-09-14T16:39:44.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148274

AvKare (Pulaski, TN) has withdrawn one lot of sildenafil 100 mg tablets and one lot of trazodone 100mg tablets due to a product mix-up that led them to be inadvertently packaged together during bottling at a third-party facility. Unintentional consumption of sildenafil may pose serious health risks because the drug may interact with nitrates found in some prescription drugs (such as nitroglycerin), a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/avkare-issues-voluntary-nationwide-recall-sildenafil-100mg-tablets-and-trazodone-100mg-tablets-due?ref=fdaweb.com) says. Unintended intake of trazodone may result in adverse health consequences such as somnolence/sedation, dizziness, constipation, and blurred vision, it adds. Sildenafil is used for treating erectile dysfunction and is packaged in 100 count bottles. Trazodone hydrochloride is indicated for treating major depressive disorder and packaged in 1,000 count bottles.